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Studies of renal injury III: Lipid-induced nephropathy in type II Progressive renal fibrosis is a consequence of multiple
diabetes. types of renal injury [1–9]. The end result is expansion of
Background. Nephrotoxicity from elevated circulating lipids the interstitial space by accumulated extracellular proteinsoccurs in experimental and clinical situations. We tested the
that compromise tubular and glomerular function [1].hypothesis that lipid-induced nephropathy causes advanced
The evolution of fibrosis is complex, and often the pre-renal failure in rats with type II diabetes and dyslipidemia.
Methods. First generation (F1) hybrid rats derived from the dominant pathology is tubulointerstitial disease [10–12],
spontaneous hypertensive heart failure rat (SHHF/Gmi-fa) and which is frequently associated with glomerulosclerosis
the LA/NIH-corpulent rat (LA/N-fa) were studied for 41 weeks [11–13]. These two features comprise renal fibrosis, thewhile being on specific diets. Group 1 (14 rats) ingested 11.5%
most accurate predictor for progression to end-stage re-protein, 47.9% fat, and 40.6% carbohydrate. Group 2 (8 rats)
nal disease (ESRD) [14, 15].ingested 26.9% protein, 16.7% animal fat, and 56.4% carbohy-
drate, and group 3 (20 rats) ingested 20.2% protein, 40.4% soy Experimental evidence linking hyperlipidemia to re-
and coconut oil, and 39.4% carbohydrate. nal injury and progression of renal fibrogenesis has been
Results. Hyperglycemia was more severe in rat groups 1
obtained [16–23]. Lipids modulate the progression ofand 2 than in group 3. In contrast, circulating cholesterol and
chronic renal diseases [19, 22, 23] and may even be pri-hydroperoxide levels were highest in group 3, intermediate in
group 2, and lowest in group 1. Group 3 had severe renal failure mary factors in the pathogenesis of renal tissue injury
secondary to glomerulosclerosis and tubulointerstitial disease, [17, 20, 24]. The presence of endogenous hyperlipidemia
with striking deposition of the lipid peroxidation stress bio- (with or without nephrotic syndrome) or the ingestion
marker 4-hydroxynonenal in glomeruli and renal microvessels.
of diets rich in cholesterol hasten the development ofMoreover, in group 3, increased arterial wall thickness also
renal fibrosis in a variety of experimental models of renalconnoted vascular injury. In contrast, the glycoxidation stress
biomarkers pentosidine and carboxymethyl-lysine were prefer- disease [16, 17]. Moreover, specific antilipemic therapy
entially localized to renal tubules of hyperglycemic rats in rectifies the decline in renal function in obese rats and
groups 1 and 2 and did not segregate with the most severe renal also in normal rats with reduced renal mass or injuredinjury. Glomerular and interstitial fibrosis was accompanied by
by cytotoxic agents [16]. It is noteworthy that in theseproportional increases in renal transforming growth factor-b1
hyperlipidemic rats renal accumulation of fatty acids pluslevels, which were threefold higher in the hypercholesterolemic
rats of group 3 than in the hyperglycemic rats of group 1. cholesteryl esters occurs concurrently with progression
Conclusions. Acquisition of non-nodular glomerular sclero- of tubulointerstitial fibrosis and glomerulosclerosis. It is
sis and tubulointerstitial disease is dependent on lipoxidation not clear how feeding cholesterol may evoke renal toxic-stress in rats with type II diabetes. On the other hand, in the
ity, although there is a widely held belief that the injuryabsence of hypercholesterolemia, prolonged glycoxidation stress
does not appear to be uniquely nephrotoxic. process may be mediated by oxidized low-density lipo-
protein (LDL) [22, 25].
We studied the renal injury of rats with type II diabetesKey words: diabetic nephropathy, oxidant-mediated injury, nephrotox-
icity, hyperglycemia, glomerulosclerosis. and diet-induced dyslipidemia and found a direct linkage
between ingestion of specific diets, elevations of bloodReceived for publication January 14, 1999
LDL cholesterol plus hydroperoxide, renal production ofand in revised form August 2, 1999
Accepted for publication August 23, 1999 transforming growth factor-b1 (TGF-b1), renal fibrosis,
and kidney failure. The underlying renal lesion included 2000 by the International Society of Nephrology
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glomerulosclerosis, interstitial fibrosis, and tubular de- CX4CE Clinical System in 400 mL of blood drawn from
the tail vein. Plasma lipid hydroperoxides were deter-generation. The lipid-dependent lesions were associated
with imprints of lipid peroxidation in interstitial mi- mined spectrophotometrically by Fe21 oxidation in the
presence of xylenol orange [29]. The assay was linearcrovessels and glomeruli. In contrast, advanced glycation
end products accumulated in renal tubules but were not for up to 20 mL of rat plasma. For each assay, an aliquot
of plasma was diluted to 90 mL with H2O and assayed forlinked to the most severe renal pathology.
hydroperoxides exactly as described [29]. Blanks were
determined by quenching peroxides with 10 mL of 10
METHODS
mmol/L methanolic triphenylphosphine prior to the ad-
Animals dition of the ferrous xylenol orange reagent [29]. All
assays and blanks are averages of triplicate determina-The pathogen-free rats used in these investigations
were from Genetic Models, Inc. (Gmie; Indianapolis, tions, which invariably agreed within 10%. The results
were expressed as mmol of lipid hydroperoxide. PlasmaIN, USA). We studied only first generation (F1) hybrid
rats derived from two well-characterized parental strains: renin activity (PRA) was measured by radioimmunoassay
with the INCSTAR kit, as recommended by the manufac-the spontaneous hypertensive heart failure rat (SHHF/
Gmi-fa) [26, 27] and the LA/NIH-corpulent rat (LA/N-fa), turer (Incstar Corporation, Stillwater, MN, USA). PRA
was based on the amount of angiotensin I generated ina normotensive strain with hyperlipidemia [28]. The ani-
mals were maintained in the Gmi animal facility from the unknown plasma samples after 18 hours of incubation
at 378C. The final angiotensin I concentration in eachbirth until termination at 47 weeks of age. The rats were
housed in steel cages and acclimatized to 12-hour cycles unknown sample was calculated from a standard curve
generated with known concentrations of angiotensin I.of light and darkness (7 a.m. to 7 p.m.). The ambient
temperature was 708F, and food and water were available
Gel filtration chromatographyat all times.
There were 20 females and 22 males rat litter mates, Lipoproteins were separated by gel filtration of 100
mL aliquots of rat plasma (Superose 6 10/30; Pharmacia,which were randomly assigned to three main diet groups
after 6 weeks of age and continued to age 47 weeks. The Piscataway, NJ, USA). The elution buffer was made of
150 mmol/L NaCl and 20 mmol/L HEPES, pH 7.4, andfirst group of 14 rats ingested GMIe diet #13004, which
consisted of 11.5% protein, 47.9% fat, and 40.6% carbo- also contained 0.02% NaN3. The column flow rate was
0.25 mL/min, and 0.5 mL fractions were collected se-hydrate. The second group of eight rats ingested Purinae
diet #5008, which contained 26.9% protein, 16.7% ani- quentially. The serum fractions were assayed for choles-
terol and triglyceride using commercially available kitsmal fat, and 56.4% carbohydrate. The third group of 20
rats ingested GMIe diet #12455A, which consisted of (Roche Pharmaceuticals, Indianapolis, IN, USA). Hu-
man plasma was used to standardize the column (data20.2% protein, 40.4% soy and coconut oil, and 39.4%
carbohydrate. The gross energy total of these diets was not shown).
comparable and averaged 4.5 kCal/g. The body weights
Renal histology and immunohistochemistryand blood metabolic profiles of the rats were monitored
throughout the experiment (discussed later in this arti- Renal histology and immunohistochemistry were con-
ducted on paraffin-embedded renal sections at termina-cle). Blood samples were obtained by tail vein drawings
and during the terminal blood collection. The appear- tion. Transverse renal sections of 5 mm thickness were
stained with trichrome for evaluation. Morphometricance of diabetes was verified by serial determinations of
blood glucose levels and also by sequential oral glucose analysis was performed at 3200 magnification, as de-
scribed previously [30]. This analysis was conducted bytolerance tests. The oral glucose tolerance tests were
obtained at 1, 21, and 31 weeks after assignment to the an examiner that was blinded to the identity of the kidney
sections. Each entire kidney section was analyzed, andrespective diet group. At 8 a.m., blood glucose levels
were measured and defined as zero time; then at 30, 60, all glomeruli and tubules were included in the calcula-
tions. The presence of any degree of glomerular sclerosis,and 120 minutes following a load of 2.5 g/kg of glucose
given by gavage the animals were measured again. ranging from focal to global lesions, was considered posi-
tive. Tubular atrophy was characterized by epithelial cellEleven rats died in the course of the experiment: 10 rats
were on diet #12455A, and one rat was on diet #13004. attenuation and by tubular cystic dilation. Glomerular
and tubular data were expressed as fractions of the total
Blood analysis number of glomeruli and tubules. The degree of interstitial
fibrosis was calculated as a fibrosis index, which was ob-Unless indicated otherwise, results from blood analysis
were obtained at the end of the experiment. The blood tained from all areas covered by fibrosis. The scale param-
eters were grade 0, indicating absence of fibrosis; grade 1,levels of triglyceride, cholesterol, creatinine, and blood
urea nitrogen (BUN) were measured on a Beckman representing fibrosis involving 5% of the surface area;
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grade 2, indicating fibrosis involving 5 to 10% of the Renal vascular morphometry
surface area; grade 3, fibrosis involving 10 to 25%; and The cross-sectional wall area of all small renal arteries
grade 4, fibrosis involving a surface area greater than 25%. was measured in paraffin-embedded sections. The renal
Immunohistochemistry was carried out on 5 mm renal vessels were first identified by immunohistochemistry.
sections mounted on lysine-coated glass [31]. The tissue Renal arteries were labeled with a primary monoclonal
sections were deparaffinased by sequential exposure to antibody to a-smooth muscle actin, clone 1A4 (Sigma,
xylene and ethanol. We employed the Vectastaine im- Chemical Co., St. Louis, MO, USA), followed by a sec-
munostaining protocol as described by the manufacturer ondary goat antibody to mouse immunoglobulin (Vector
(Vector Laboratory, Burlingame, CA, USA). The sec- Laboratory). All cross-sectional areas of cortical and
tions were dehydrated and then exposed to H2O2 to elimi- medullary arteries available to inspection were measured
nate endogenous peroxidase activity. The kidney sec- [35]. The renal images were collected with a CCD/RCB
tions were then blocked with 2% bovine serum albumin color video camera (Sony Model DXC-151, Tokyo, Ja-
(BSA) for 30 minutes and exposed to either of two pri- pan) mounted on a Leitz Loborlux S microscope (Leitz
mary antibodies to test for evidence of either lipid peroxi- USA, Rockleigh, NJ, USA). The total cross-sectional
dase product or advanced-glycation end product (AGE), vessel area (comprising wall and lumen) and the respec-
respectively. To test for lipid peroxidation injury, we tive luminal area were measured. The results were ex-
used specific polyclonal antibody to 4-hydroxynonenal- pressed as fractional arterial wall area (luminal area/
keyhole limpet hemocyanin (4-HNE-KLH) raised in rab- total artery area). The data were processed with the
bits, which were immunized with dialyzed keyhole lim- NIH Imaging System version 1.57 (National Institutes of
pet hemocyanin previously reacted with 4-HNE [32]. Health, Bethesda, MD, USA), running on a MacIntosh
The antiserum was used at a dilution of 1:1000. The Quadra 900 model M4200 computer (Apple Computer,
nitrotyrosine biomarker was detected with specific rabbit Cupertina, CA, USA).
antinitrotyrosine antibody raised in rabbits against ni-
Enzyme-linked immunoabsorbent assaytrated-keyhole limpet hemocyanin. The antibody was
manufactured by Upstate Biotechnology (Lake Placid, Specific renal proteins were quantitated by enzyme-
NY, USA). This antibody was tested at a dilution of linked immunosorbent assay (ELISA) in kidneys from
1:500. To test for advanced glycoxidation injury, we used the three groups of rats [36]. The kidneys were homoge-
specific polyclonal antibody to the AGE, Nv-(carboxy- nized on ice with a glass/Teflon homogenizer in TES-PI
methyl)lysine (CML) raised in rabbits immunized with buffer containing (in mmol/L): Tris HCl, 20; sucrose,
purified CML [33]. The CML antigen was prepared by 255; and ethylenediaminetetraacetic acid (EDTA), 1;
reaction of glyoxylic acid with BSA in the presence of plus leupeptin, 5 mg/mL; pepstatin, 5 mg/mL; and aproti-
NaBH3CN, as previously reported [33]. The CML con- nin, 5 mg/mL, pH 7.4 [36]. The renal homogenates were
tent in this preparation was determined by amino acid diluted in phosphate-buffered saline (PBS; 10 mg/mL),
analysis after acid hydrolysis [33]. We used a second anti- and 100 mL aliquots were used to coat the wells of ELISA
CML antibody raised in rabbits immunized with carboxy- plates overnight (all reactions were conducted at room
methylated-keyhole limpet hemocyanin. The initial im- temperature). In the case of carboxymethyl-lysine mea-
munization was followed by booster injections with car- surements, the homogenates were treated with collagen-
boxymethylated ribonuclease given weekly until an ase type II, 1 mg/mL, for one hour at 378C. The plates
appropriate titer was reached. The primary CML antise- were washed three times with 0.05% Tween-20 in PBS
rum was used at a dilution of 1:1000 and 1:3000. The and were then coated with 5% BSA or 1% teleost gelatin
negative controls were exposed to preimmune rabbit in PBS for two hours. The wells were again washed, and
serum in all cases. The pentosidine antibody was raised 100 mL aliquots of primary antibody were added to the
in rabbits against pentosidine as previously reported [34]. wells (anti-4HNE 1:3000, antinitrotyrosine 1:500, anti-
The antibody was used at a dilution of 1:1000. CML 1:3000, and antipentosidine 1:500). The negative
After washing off the unbound primary antibody, or controls contained preimmune rabbit serum. The plates
preimmune serum, the kidney sections were exposed to were incubated overnight and washed, and 100 mL of
biotinylated secondary antibody. The goat antirabbit the second antibody, goat antirabbit IgG-HRP, were
IgG was diluted to 1:400 in 10% goat serum. The sections added for four hours. The plates were washed, and
were washed and incubated with avidin-conjugated horse- 3,39,5,59-tetramethyl benzidine (TMB) substrate (Vec-
radish peroxidase (HRP) and reacted with 3% H2O2 in tor) was added for one hour. The reaction plates were
1 mol/L imidazole with 10 mg/mL of horse peroxidase read at 405 nm wavelength.
substrate (DAB; Vector Laboratory). The sections were Renal transforming growth factor-b1 (TGF-b1) levels
then stained with hematoxylin eosin and analyzed by were measured by a sandwich ELISA protocol. The two
anti–TGF-b1 antibodies and ELISA protocol were fromlight microscopy.
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R&D Systems (Minneapolis, MN, USA). Briefly, wells in grams were 285 6 8, 237 6 7, and 251 6 7, respectively.
of ELISA plates were coated with monoclonal antibody At the age of 47 weeks, the animals were morbidly obese,
to human TGF-b1 (2 mg/mL) diluted in PBS and incu- with average weights of 968 6 20, 837 6 54, and 1118 6
bated at room temperature overnight. The plates were 86 g for each cohort (Fig. 1A). The body weight curves
washed three times with 0.1% Tween-20 in PBS and plotted as a function of time were not statistically differ-
soaked in blocking buffer: 5% Tween-20, 5% sucrose, ent from one another. Thus, unlike other diabetic animal
0.1% Na3N in PBS. The kidneys were homogenized in models [37], the severity of diabetes (discussed later in
PBS with 0.2 mol/L HCl, 0.1% Tween-20, and 0.2% this article) did not affect the growth of these robust
blotting grade Blocker (Bio-Rad, Hercules, CA, USA). animals. Although obesity was associated with marked
After 10 minutes at room temperature, the pH in the glucose intolerance, notable differences were observed
samples was neutralized by adding 1.2 N NaOH with as a function of time in the three diet groups. After one
0.5 mol/L HEPES. Any residual insoluble tissue was week on the diets, all three groups showed comparable
separated by centrifugation (2000 3 g for 10 min at 58C). degrees of glucose intolerance (Fig. 1B). However, after
The blocked wells were then washed three times with 21 weeks on the diets, glucose intolerance was particu-
0.1% Tween-20 in PBS, and triplicate aliquots of renal larly severe in the group ingesting the 5008 diet (Fig.
samples (1:1 and 1:2 dilution) plus triplicate TGF-b1 stan- 1C; P , 0.05). Whereas the group on diet 13004 remained
dards (1000, 500, 200, 100, 50 pg/mL in 0.1% Tween-20, glucose intolerant for the duration of the experiment,
with 0.2% blotting grade Blocker, in PBS) were applied the group on diet 12455A depicted near normalization
at room temperature for two hours. TGF-b1 standards of its glucose tolerance in the final test at 31 weeks (Fig.
were also added to the fresh homogenates to calculate 1D; P , 0.05).
recovery, which was 100%. The wells were washed three Hyperglycemia followed a similar temporal pattern,
times with 0.1% Tween-20 in PBS three times, and pri- with random blood glucose averaging 12.9 6 1.1, 11.6 6
mary chicken polyclonal antibody to TGF-b1 was added 1.1, and 11.1 6 0.6 mmol/L in each respective group at
(0.2 mg/mL in 0.1% Tween-20, with 0.2% blotting grade the time of diet assignment (6 weeks of age). These
blocker, in PBS) at room temperature for three hours. values were not statistically different (Fig. 2A). How-
After washing the wells three times with 0.1% Tween- ever, once on their specific diets, the highest glucose
20 in PBS, the samples were reacted with secondary levels were observed in rats on diet 5008 (P , 0.05). At
antibody: 1:10,000, HRP-conjugated rabbit antibody to the end, rats on diet 5008 and 13004 remained hypergly-
chicken immunoglobulin mixed in PBS with 1% Tween- cemic, 9.9 6 0.9 and 8.8 6 0.4, respectively. In contrast,
20, 0.2% blotting grade blocker for one hour at room rats on diet 12455A had lower glucose levels, 7.0 6 0.1.
temperature. The wells were then washed three times
It is relevant that 9 out of 20 rats died 30 to 35 weeks afterwith 0.1% Tween-20 in PBS, and then TMB (Pierce,
ingesting diet 12455A, and whereas the overall change inRockford, IL, USA), 0.4 g/L in water, was added along
subsequent glucose values did not appear to be influencedwith 0.02% hydrogen peroxide (1:1). The reaction was
in this cohort (Fig. 2A), the group change in cholesterolstopped after one hours with 2 mol/L H2SO4 and then levels was attenuated (discussed later in this article).read at 405 nm wavelength.
As shown in Figure 2B, the different diet formulations
evoked diverse effects on the sequential levels of plasmaMaterials
cholesterol. At the time of diet assignment, cholesterolBovine serum albumin was from ICN Biomedicals (Ir-
levels averaged 1.76 6 0.06, 1.92 6 0.07, and 1.91 6vine, CA, USA). Type II collagenase was from Boeh-
0.05 mmol/L in diet groups 5008, 13004, and 12455A,ringer Mannheim, Corp. (Indianapolis, IN, USA). Tele-
respectively. The average increase in cholesterol for theost gelatin, leupeptin, pepstatin, aprotinin, and all other
rats in diet 12455A was pronounced after only threereagent grade chemicals were from Sigma Chemical Co.
weeks on the diet. This profound effect persisted for the
Statistical analysis duration of the experiment. The averaged cholesterol
value after 42 weeks on the diet was 8.75 6 1.02 mmol/L.The data are expressed as mean 6 sem. Statistical
This final average value is lower than that obtained atdifferences between groups were calculated by analysis
30 weeks, 15.54 6 1.92 mmol/L, reflecting the dying outof variance with Bonferroni’s t-test and by Spogtvoll/
of nine of the most severely hypercholesterolemic rats.Stoline test for unequal numbers (Statistica, Stat Soft
Plasma cholesterol levels were also elevated in rats in-version 4.5, Tulsa, OK, USA).
gesting diet 5008, although the increases were less pro-
nounced, with a final value of 4.67 6 0.46 mmol/L. It is
RESULTS noteworthy that rats on diet 13004 did not show signifi-
Obesity and metabolic profiles cant changes in their plasma cholesterol level, and their
final averaged measurement was 2.57 6 0.16 mmol/L.At six weeks of age, the rats were assigned to the diet
groups 5008, 13004, and 12455A, and their average weights When sequential cholesterol levels were plotted as a
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Fig. 1. Obesity and oral glucose tolerance
test (OGTT). (A) Progressive and comparable
increase in body weight was observed in all
rats in diet groups 5008 (s), 13004 (j), and
12455A (d). (B) Oral glucose tolerance test
after one week on the diets. (C) Oral glucose
tolerance test after 21 weeks on the diets. (D)
Oral glucose tolerance test after 31 weeks on
the diets (P , 0.01 for 12455A diet group vs.
either 13004 or 5008 diet groups, ANOVA).
function of time, the three diet groups were statistically the lowest BUN levels, 1.37 6 0.08 mmol/L (P , 0.05
different from each other (Fig. 2B; P , 0.05). vs. the other two diet groups). Whereas rats on diet
In marked contrast, the greatest elevation of plasma 12455A had the highest BUN level (8.05 6 0.65 mmol/L;
triglyceride levels was in the group ingesting diets 5008 P , 0.05 vs. the other two diet groups), the rats on diet
and 13004 (Fig. 2C). At the time of diet assignment, 5008 had an intermediate level between the other two
triglyceride levels averaged 2.36 6 0.28, 1.64 6 0.154, diet groups (4.37 6 0.67 mmol/L).
and 1.67 6 0.11 mmol/L in diet groups 5008, 13004, and Terminal plasma creatinine levels were distributed in
12455A, respectively. However, after only three weeks the same proportion as BUN levels (Fig. 4B). Thus, rats
on the diet, triglyceride levels increased in the groups on diet 13004 had the lowest levels of plasma creatinine
fed diets 5008 and 13004. Their final triglyceride levels (37 6 1 mmol/L; ANOVA, P , 0.05 vs. the other two
were 11.71 6 1.89 and 33.89 6 7.59 mmol/L, respectively. diet groups), whereas rats on diet 12455A had the highest
On the other hand, triglyceride levels only showed an levels of creatinine (66 6 7 mmol/L; ANOVA, P , 0.05
increase after 24 weeks on the rats on diet 12455A, and vs. the cohorts on diets 13004 and 5008). The creatinine
their final values averaged 5.92 6 1.62 mmol/L. When levels on the rats on diet 5008 occupied an intermediate
all sequential blood triglyceride levels were plotted as a position between the other two groups (49 6 3 mmol/L).
function of time, the latter group was significantly lower
than the other two groups (P , 0.05; Fig. 2C). Metabolic and renal function parameters
The distribution of plasma lipoproteins was appraised
The results indicate that feeding specific formulations,by gel filtration chromatography (Fig. 3). In rats ingesting
that is, diet 12455A, and to a lesser extent diet 5008,either diet 5008 or 12455A, most of the cholesterol was
caused hypercholesterolemia and severe renal dysfunctiondistributed in fractions corresponding to very low density
in obese rats. Accordingly, the potential association be-lipoproteins (VLDLs) and LDLs. In contrast, rats ingest-
tween metabolic and renal function parameters was eval-ing diet 13004 depicted a very different profile, with most
uated. When the dependent variable was terminal cho-of the cholesterol present in high-density lipoproteins
lesterol levels, terminal BUN levels varied in near direct(HDLs). The triglyceride content of lipoprotein fractions
proportion (Fig. 5A). It is noteworthy that simultaneousis shown in Figure 3B. There was no difference among
plasma creatinine levels also increased in direct propor-rats on different diets; all of the measurable triglyceride
tion to the levels of cholesterol (Fig. 5B). In contrast,was present in the VLDL region.
plasma levels of triglyceride, or glucose, did not correlate
Renal function with levels of BUN or plasma creatinine (data not shown).
The levels of plasma hydroperoxide were also mea-Plasma BUN was measured in all rats at the end of
the experiment (Fig. 4A). The rats on diet 13004 had sured. This analysis reflected the oxidized state of the
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Fig. 3. Gel filtration chromatography of plasma lipoproteins. (A)
Plasma cholesterol from rats on diet 5008 and 12455A was distributed
in fractions corresponding to very low-density lipoproteins (VLDLs)
and low density-lipoproteins (LDLs). Plasma cholesterol from rats on
diet 13004 was distributed in fractions corresponding to high-density
lipoproteins (HDL). (B) Plasma triglyceride from all rats was distributed
in the VLDL and LDL regions. The vertical scale represents arbitrary
numbers and the horizontal scale the number of fractions. Symbols are:
(r) diet 5008; (j) diet 13004; (m) diet 12455A.
direct proportion (Fig. 5C). It is noteworthy that plasma
creatinine levels also increased in direct proportion to
the levels of plasma hydroperoxide (Fig. 5D). However,
the ANOVA for independent variables revealed that
levels of cholesterol and hydroperoxide did not contrib-
ute independently to the variation observed in plasma
Fig. 2. (A) Glucose, cholesterol, and triglycerides while on the respec- creatinine levels.
tive diets. The elevated glucose levels improved gradually with time.
However, rats on diet 12455A had the lowest levels throughout the
Renal histology and immunohistochemistryexperiment (P , 0.01). (B) In contrast, cholesterol levels were much
higher in the 12455A diet group (P , 0.01). (C) The rats on diet 5008
The individual diets evoked remarkably different ef-had the highest levels of triglyceride (P , 0.01). Symbols are: (s) diet
5008; (j) diet 13004; (d) diet 12455A. fects on kidney mass and morphology. The findings ranged
from relatively normal renal tissue in rats that ingested
diet 13004 (Fig. 6) to advanced tubulointerstitial renal
blood samples, and the hydroperoxide level was strongly disease in the rats that ingested diet 12455A (Fig. 6).
correlated with the cholesterol level in each individual The rats that ingested diet 5008 also had significant renal
rat. Moreover, when plasma hydroperoxide levels served pathology, represented by tubulointerstitial fibrosis and
glomerular sclerosis. However, in this cohort of animalsas the dependent variable, BUN levels varied in near
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nenal in mesangial regions of glomeruli. The label was
strongly positive in the renal sections from the animals
that ingested diet 12455A, illustrated by the 2.50 6 0.26-
fold increase over the 13004 diet group by ELISA (P ,
0.02). Renal 4-hydroxynonenal in the 5008 diet had a
highly variable fold increase over the 13004 diet group,
2.51 6 0.77 (P . 0.05).
A potential pathway to injury involves reactions be-
tween superoxide anion and nitric oxide, which create
the strong oxidant peroxynitrite [39]. Accordingly, kid-
ney peroxynitrite-modified proteins [40] were identified
and measured. Kidneys from rats that ingested diet 13004
had the most prominent label to peroxynitrite residues
(data not shown), although kidneys from rats that in-
gested diets 5008 and 12455A also had noticeable im-
prints to peroxynitrite. The label was present in renal
tubules of cortex and medulla. There was also some label-
ing of peroxynitrite in mesangial regions of glomeruli (data
not shown). These results were confirmed by ELISA.
Nitrotyrosine kidney levels in rats on diets 12455A and
5008 were only 0.76 6 0.04 (P , 0.01) and 0.75 6 0.24
(P . 0.05) of the renal levels found in the rats on diet
13004. Thus, hydroxynonenal epitopes, which imply lipid
peroxydation, were particularly abundant in the kidneys
of the most dyslipidemic rats (diet 12455A). In contrast,
nitrotyrosine residues, indicators of peroxynitrite-modi-
fied proteins, were less conspicuous in this group.
Persistent hyperglycemia also placed the rats in jeop-
ardy for renal glycoxidation. In this complication, AGEs
generated by nonenzymatic glycation can cause oxidative
stress to exposed cells [41]. Likewise, oxidation reactions
have the potential of promoting glycation of proteins un-
Fig. 4. Plasma blood urea nitrogen (BUN) and creatinine levels. (A) der appropriate circumstances [42]. Accordingly, markers
The highest levels of BUN were on rats on diet 12455A, and in decreas- for renal glycoxidation were investigated with specific
ing order in rats on diet 5008 and 13004 (all values significantly different
antibodies to the AGEs CML and pentosidine. Tests werefrom each other; P , 0.01, ANOVA). (B) The highest levels of creati-
nine were on rats on diet 12455A, followed by rats on diet 5008 and conducted with two independent anti-CML antibodies
13004 (all values significantly different from each other; P , 0.05, (Methods section), which yielded comparable results
ANOVA).
(Fig. 6). The renal CML label appeared stronger in the
kidneys of rats that ingested diets 13004 than in the diet
groups 5008 and 12455A. CML was preferentially local-
ized to cortical renal tubules (Fig. 6). These results werethe renal injury was not nearly as severe as that observed
in the rats that ingested diet 12455A (Fig. 6). verified independently by ELISA. CML kidney levels in
rats on diets 12455A and 5008 were 0.68 6 0.05 (P ,The mechanism of the renal injury was examined with
specific biomarkers for lipid peroxidation and glycoxida- 0.02) and 0.83 6 0.03 (P , 0.05) of the renal levels found
in the rats on diet 13004.tion in renal tissues. The presence of the cytotoxic alde-
hydic lipid peroxidation product 4-hydroxynonenal [38] Pentosidine is another mediator of glycoxidation in-
jury, and it has been localized to glomeruli and tubuleswas investigated with antibody to 4-HNE-KLH. The la-
bel to 4-hydroxynonenal was weak or nonexistent in sec- of diabetic subjects with nodular nephropathy [34]. The
markings for pentosidine were also stronger in renaltions of rats that ingested diet 13004 (Fig. 6). On the
other hand, rats that ingested diets 5008 and 12455A had tubules of rats on diets 13004 and 5008 than in the rats
that ingested 12455A (data not shown). These resultsprominent markings localized to the interstitial space and
to the microvessels of the medulla and papilla boundary. were also confirmed by ELISA. Pentosidine kidney lev-
els in rats on diets 12455A and 5008 were 0.73 6 0.01Indeed, the label was particularly strong in the inner
medulla and papilla, where it appeared as longitudinal (P , 0.02) and 1.02 6 0.03 (P . 0.05) of the renal levels
found in the rats on diet 13004.streaks (Fig. 6). There was also labeling of 4-hydroxyno-
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Fig. 5. Relationship of plasma cholesterol and
hydroperoxide with renal function parameters.
Plasma cholesterol correlated with plasma
BUN (A; r 2 5 0.74, P , 0.0001) or creatinine
(B; r 2 5 0.83, P , 0.0001). Plasma hydroperox-
ide also correlated with BUN (C; r 2 5 0.72,
P , 0.0001) and creatinine (D; r 2 5 0.40, P ,
0.0003). The positive correlation between cho-
lesterol and hydroperoxide was also very
strong (P , 0.0001, data not shown).
The striking differences in the degrees of glomerulo- Whereas arterial blood pressure was not measured,
end-organ damage derived from hypertension was esti-sclerosis, tubular atrophy, and interstitial fibrosis were
mated from measurements of small caliber renal arteriesconfirmed by renal histomorphometry (Fig. 7). The re-
(Table 1). All arterial cross-sectional areas available forspective fractions of sclerotic glomeruli for diets 13004,
inspection were measured. The individual arterial cross-5008, and 12544A were 2.16 6 0.41, 9.54 6 1.21, and
sectional areas ranged in averages from 11 to 23 mmol/L231.39 6 2.31 (all significantly different from each other,
and were not statistically different between groups. Con-P , 0.01, ANOVA). There were also significant differ-
versely, fractional areas comprising only arterial wallsences in the degree of tubulointerstitial disease repre-
were significantly expanded in the arteries of rats fedsented by tubular atrophy and interstitial fibrosis. The
diet 12455A.percentage of atrophic tubules from rats on diets 13004,
5008, and 12455A averaged 2.58 6 0.61, 8.82 6 0.37, and
Renal transforming growth factor-b1
34.92 6 5.75 (all significantly different from each other,
The potential involvement of TGF-b1 in diet-depen-P , 0.01, ANOVA,). The corresponding values for renal
dent glomerulosclerosis and interstitial fibrosis was eval-fibrosis index [1–4, 43] were 0.65 6 0.14, 1.52 6 0.07,
uated, and significant differences in the level of renaland 3.43 6 0.18 (all significantly different from each
immunoreactive TGF-b1 were detected in the three di-other, P , 0.01, ANOVA). The kidney weights of the
etary groups (Fig. 8). Renal TGF-b1 was 141 6 25 (pg/mgrats that ingested diets 13004, 5008, and 12455A had a
total kidney protein) in hyperglycemic rats fed diet 13004,similar distribution: 0.225 6 0.008, 0.265 6 0.008, and
279 6 32 in hyperglycemic and cholesterolemic rats fed0.341 6 0.046 g/100 g body wt, respectively. These values
diet 5008, and 428 6 36 in severely hypercholesterolemicwere statistically different from each other (P , 0.01,
rats fed diet 12455A. These values were significantly dif-ANOVA).
ferent from each other (ANOVA, P , 0.05). It is notewor-
thy that renal TGF-b1 levels were distinctly higher inRenin activity and renal vascular morphometry
these diabetic rats than in kidneys of normoglycemic
Because oxidized lipoproteins are potent stimulants Sprague Dawley rats of the same age, 34 6 4 pg/mg
of renin release in vitro and renal injury could potentially protein (N 5 3).
result from this process [44], PRA levels were also mea-
sured. PRA determinations, expressed as ng/mL/h, were
DISCUSSIONnot statistically different in any of the three groups (Ta-
ble 1). In fact, PRA levels were in the low range for rats, A linkage among ingestion of atherogenic diets, dyslip-
idemia, and oxidative renal injury in rats with type IIas reported by our laboratory [45].
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Fig. 6. Renal histology (A–C) and immunohistochemistry (D–I). Renal sections were stained with Gomori’s trichrome stain. Renal structures
from rats on diet 13004 (A) were essentially normal. In contrast, glomerular sclerosis and interstitial fibrosis apparent in rats fed diet 5008 (B)
were extremely severe in rats fed diet 12455A (C). Glomerular localization of 4-hydroxynonenal (HNE, solid arrow) was faint in rats on diet
13004 (D). HNE label was stronger in rats fed diet 5008 (E) and 12455A (F). Carboxymethyl-lysine (CML) label was prominent in proximal
tubules of rats fed diet 13004 (G) and diet 5008 (H). In contrast, the CML label was faint in tubules from rats fed diet 12455A (I). The open
arrows indicate the approximate boundary of inner medulla and renal papilla. Publication of this figure in color was made possible by Parke-Davis
Pharmaceuticals, Morris Plains, NJ.
diabetes was demonstrated. The rats were the first gener- mortality in the set ingesting diet 12455A was much
higher than in the other two groups of littermates. Theation of two disease-prone rat models: the SHHF rat
[27, 46] and the corpulent LA/N rat [47, 48]. Whereas rats on diet 12455A also had the highest levels of plasma
creatinine and BUN and the most severe renal lesions.the progeny expressed some parental features, their re-
nin levels were reduced rather than increased [27]. It is noteworthy that rats fed diet 12455A (coconut oil
supplemented with cholesterol) had higher LDL choles-The lipoprotein profile was markedly influenced by
the lipid and carbohydrate content of the diet. Obese rats terol levels, which correlated with high levels of plasma
hydroperoxide, as noted previously for humans and ratsingesting diets 5008 and 12455A had an overwhelming
predominance of circulating VLDL and LDL choles- [51, 54]. Consequently, we propose that LDL cholesterol
served as an important carrier of lipid hydroperoxides [55].terol, whereas HDL cholesterol and elevated triglyceride
was the prevailing profile in rats ingesting casein con- The atherogenicity of diet 5008 was conceivably de-
rived from fish meal, a constituent of the high-proteintaining diet 13004, as shown previously [49]. These phe-
notypical characteristics are found in other rat models diet [56], and not from the lipid formulation, which was
proportionally reduced. The rats on diet 5008 also had[50, 51] and in humans with renal disease [21, 52, 53].
The rats tolerated the diets for up to 30 weeks, when significant renal pathology, elevated cholesterol, hydro-
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Fig. 7. Renal histomorphometry. (A) The
lowest percentage of sclerotic glomeruli per
renal section was in the rats diet 13004. Rats
fed diet 5008 had a significantly higher number
of sclerosis, whereas rats on diet 12455A had
the highest percentage of sclerotic glomeruli.
(B) The lowest percentage of atrophic tubules
per renal section was in the rat’s diet 13004.
Rats fed diet 5008 had a significantly higher
proportion of tubular atrophy, whereas rats
on diet 12455A had the highest percentage of
atrophic tubules. (C) The lowest level of renal
fibrosis per renal section was in the rat’s diet
13004. Rats fed diet 5008 had a significantly
higher fibrotic index, whereas rats on diet
12455A approached the maximum fibrosis in-
dex of 4.0 (N 5 7 to 13; all values are signifi-
cantly different from each other, P , 0.02,
ANOVA).
Table 1. Renin activity and renal vascular morphometry
in the three study groups
Diets D13004 D5008 D12455A
PRA ng/ml/hr 0.660.3 1.460.2 0.960.1
N 5 13 N 5 8 N 5 10
Total arterial area mm2 0.01860.005 0.02360.007 0.01160.001
N 5 14 N 5 9 N 5 13
Fractional arterial wall 0.786 60.016 0.76060.021 0.84660.012b
areaa N 5 14 N 5 9 N 5 13
a Fractional arterial wall was calculated as measured luminal area over total
arterial area, which included arterial lumen and wall
b P , 0.05 vs. the other two groups
peroxide, BUN, and creatinine levels. Their interstitial
renal injury also had similar features. There was signifi- Fig. 8. Renal TGF-b1 levels. Immunoreactive TGF-b1 levels were nor-
cant tubular dilation and cellular atrophy, accompanied malized to renal protein content. Rats on diet 12455A (N 5 11) had
the highest TGF-b1 levels. Whereas rats on diet 5008 (N 5 8) hadby renal fibrosis and cellular infiltrates. The changes were
lower TGF-b1 levels, they were still higher than the levels measuredalso associated with variable degrees of glomerular scle- in rats on diet 13004 (N 5 10; all values significantly different from
rosis and were comparable to those reported in rats fed each other, P , 0.05, ANOVA).
cholesterol [20, 57].
It appeared that renal cytotoxicity induced by the ath-
erogenic diets was secondary to oxidation damage, as indi-
vessel wall in small caliber renal arteries. Unfortunately,cated by the presence hydroxynonenal-modified renal
we did not measure blood pressure, and thus, we cannotproteins [58, 59], which most likely were disrupted by
discern the independent role of lipids and blood pressurethis major end-product of oxidized polyunsaturated fatty
on the renal injury.acids [58, 59]. We hypothesize that the renal oxidant was
Interestingly, nitrotyrosine, a biomarker for proteinsderived from the dyslipidemic blood [55], perhaps inter-
modified by peroxynitrite [64, 65], was not unequivocallynalized via specific renal endothelial receptors (LOX1)
linked to lipid-mediated injury, as it was most prominent[60, 61], or multifunctional cell-surface receptors (Cd36)
in kidneys of hyperglycemic rats on diet 13004. Thus,[62, 63]. The severe lipoxidation stress induced by diet
12455A was also linked to significant thickening of the persistent hyperglycemia appeared to be a risk factor
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with interstitial fibrosis and tubular expression of transformingfor peroxynitrate-induced stress, which did not cause
growth factor-b. Lab Invest 74:528–537, 1996
irreversible renal pathology in our rats. 6. Medjebeur AA, Bussieres L, Gasser B, Gimonet V, Laborde
Tissue glycoxidation was also documented, as indi- K: Experimental bilateral urinary obstruction in fetal sheep: Trans-
forming growth factor-b1 expression. Am J Physiol 273:F372–F379,cated by the presence of the AGEs CML and pentosidine
1997[34, 66–69]. The residues were more prominent in renal 7. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG,
tubules of rats on diets 13004 and 5008, and it was consis- Koch KM, Floege J: Mechanisms involved in the pathogenesis of
tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Inttent with tubular uptake [70, 71]. On the other hand, the
49:666–678, 1996significance of lower renal levels for these two biomark- 8. Coimbra TM, Carvalho J, Fattori A, Da Silva CG, Lachat JJ:
ers in the rat cohort that ingested diet 12455A was less Transforming growth factor-b production during the development
of renal fibrosis in rats with subtotal renal ablation. Int J Expclear, as tubular integrity was severely compromised. In
Pathol 77:167–173, 1996any case, glycoxidation imprints occurred in the three 9. Klahr S, Morrissey JJ: Comparative study of ACE inhibitors and
sets, indicating that glycoxidation stress may not be a angiotensin II receptor antagonists in interstitial scarring. Kidney
Int 52(Suppl 63):S111–S114, 1997direct mediator of injury.
10. Eddy AA: Experimental insights into the tubulointerstitial diseaseThe pathogenic role of TGF-b1 in renal injury medi-
accompanying primary glomerular lesions. J Am Soc Nephrol
ated by lipoxidation was delineated by the large increases 5:1273–1287, 1994
11. Greenfeld Z, Stillman IE, Brezis M, Rosen S: Medullary injuryin renal TGF-b1 levels. For example, when compared
in the aging rat kidney: Functional-morphometric correlations. Eurwith our normoglycemic rat controls (and with those
J Clin Invest 27:346–351, 1997
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